PENILAIAN KINERJA KEUANGAN PT INDOFARMA (PERSERO), Tbk. DAN ENTITAS ANAK DENGAN MENGGUNAKAN ANALISIS RASIO KEUANGAN

Yuliana Yuliana

Abstract


PT Indofarma (Persero) Tbk. is a pharmaceutical company listed in Indonesia Stock Exchange (IDX). The components of the consolidated statements of financial position and consolidated statements of income are fluctuate annually that make the authors are interested in analyzing its financial performance. In this study, the authors used a descriptive case study method with the object of research on the financial statements of PT Indofarma (Persero) Tbk. and Subsidiaries from 2009 until 2013. In this study, the authors used a documentary study. Authors collected data of the company which is the object of research related to the problem to be studied in the form of financial statements of PT Indofarma (Persero) Tbk. and Subsidiaries from 2009 to 2013.
Based on the analysis of liquidity ratios, the period of the most liquid than other period is 2012 as current liabilities on the smallest period. Leverage ratio analysis results indicate that the most risky period is 2013 due to the amount payable for this period was the most high. The results of the activity ratio analysis showed the most unfavorable period was in 2013 because although the highest sales compared to other periods, but suffered a loss. The results of the profitability ratio analysis shows that in 2012 the most profitable period for obtaining the highest profit compared to other periods.


Full Text:

P2237

Refbacks

  • There are currently no refbacks.